Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis. Gueguen A, Roux P, Deschamps R, Moulignier A, Bensa C, Savatovsky J, Heran F, Gout O J Neurol Neurosurg Psychiatry. 2014 May 29. PMID: 24876183. Abstract CommentRecommendBookmarkWatch